Treatment of relapsing AML following hematopoietic stem cell transplantation

Pediatric Transplantation

Volumn 7, Issue 6, 2003, Pages 419-421

  Atlas, Mark P ^a   Lipton, Jeffrey M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; RECOMBINANT INTERFERON;

ACUTE GRANULOCYTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILDHOOD MORTALITY; DONOR; EDITORIAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; LYMPHOCYTE; RELAPSE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOCYTIC, ACUTE; PEDIATRICS; RECURRENCE; REMISSION INDUCTION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0344413634     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1397-3142.2003.00119.x     Document Type: Editorial

References (15)

1. STEVENS RF, HANN IM, WHEATLEY K, et al. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 1998: 101: 130-140.
2. NESBIT ME Jr, BUCKLEY JD, FEIG SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol 1994: 12: 127-135.
3. MORTIMER J, BLINDER MA, SCHULMAN S, et al. Relapse of acute leukemia after marrow transplantation: Natural history and results of subsequent therapy. Journal of Clinical Oncology 1989: 7: 50-57.
4. RADICH JP, SANDERS JE, BUCKNER CD, et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993: 11: 304-313.
5. SHING MMK, VOWELS M. Role of second bone marrow transplants. Bone Marrow Transplant 1993: 12: 21-25.
6. CHIANG K-Y, WEISDORF DJ, DAVIES, SM, et al. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 1996: 17: 39-42.
7. BOSI A, BACCI S, MINIERO R, et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo. Leukemia 1997: 11: 420-424.
8. PEGGS KS, MACKINNON S. Cellular therapy: donor lymphocyte infusion. Curr Opin Hematol 2001: 8: 349-354.
9. VETTENRANTA K, HOVI L, SAARINEN-PIHKALA UM. Adoptive immunotherapy as consolidation of remission in pediatric AML relapsing post-transplant. Pediatr Transplant 2003: 7: 446-449.
10. LEVINE JE, BRAUN T, PENZA SL, et al. Prospective Trial of Chemotherapy and Donor Leukocyte Infusions for Relapse of Advance Myeloid Malignancies After Allogeneic Stem-cell Transplantation. J Clin Oncol 2002: 20: 405-415.
11. SHIOBARA S, NAKAO S, UEDA M, et al. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplant 2000: 26: 769-774.
12. KOLB HJ, SCHATTENBERG A, GOLDMAN JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patient. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995: 86: 2041-2050.
13. MEHTA J, POWLES R, KULKARNI S, et al. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients. Bone Marrow Transplant 1997: 20: 129-135.
14. MEHTA J, POWLES R, SINGHAL S, et al. Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995: 16: 133-137.
15. COLLINS RH, SHPILBERG O, BROBYSKI WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997: 16: 433-444.